The Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy brand, founded in 2006 (France), from 2757 sister brands and 17477 competing brands. Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy is a brand of SANOFI, listed on the stock exchange of Paris. The International Securities Identification Number (ISIN) of SANOFI is FR0000120578. The sector of Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy is Drug Manufacturers.
Share price and profitability of the share SANOFI (Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy)
Buy SANOFI share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.
Investment simulator :
Portfolio valuation
SANOFI
(Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy)
over 5 years*
EUR 105.25
Stock market history SANOFI (Credit Cardiovascular Risk Evaluation in people with type 2 Diabetes on Insulin Therapy)
*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances
past performances do not prejudice future performances
